The India Diabetes Market is expected to grow US$ 7441.6 Million by 2023 from US$ 4778.7 Million in 2016. Diabetes is a chronic metabolic disease that causes high blood sugar due to which body becomes incapable of producing insulin. According to World Health Organization (WHO), India had 69.2 million people living with diabetes (8.7%) in 2015. About 90% of the patients are suffering from Type 2 diabetes.
Increasing awareness, increasing number of patients, untouched rural market, increasing urbanization, developing healthcare infrastructure and increasing spending on healthcare are driving the market for diabetes in India. India Diabetes Market is expected to grow at the average CAGR of 6.5% during 2016-2023. India Diabetes Market is growing rapidly.
India Diabetes Market Segments:
India Diabetes Market has been segmented on the basis of type which comprise Type 1, Type 2, and Gestational diabetes. On the basis of test market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others. On the basis of devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others. On the basis of treatment, market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/2966 .
Key Players for India Diabetes Market:
Novo Nordisk A/S (Denmark), USV Private Limited (India), sanofi-aventis U.S. LLC (US), Novartis AG (Switzerland), Merck & Co., Inc. (US), Becton Dickinson and Company (US), Roche Diabetes Care, Inc.(US),Johnson & Johnson Services, Inc.(us), Bayer AG (Germany), Ypsomed (Switzerland).
Regional Analysis of India Diabetes Market:
Considering the scenario of the Indian diabetes market, western region is believed to be the largest market for diabetes. Moreover the Eastern and Northern regions are also growing and second largest market for India Diabetes. On the other hand, Southern Indian market is expected to grow at significant rate in the India diabetes during the forecasted period. Central region is likely to have a limited but moderate growth in the market.
Major TOC For India Diabetes Market – Forecast To 2023:
1. Report Prologue
2.2 Scope Of The Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
Browse Complete 60+ Premium Pages Report Enabled with Competitive Analysis of Niche Segments, Top Players, Comprehensive Research and Key Regions @ https://www.marketresearchfuture.com/reports/diabetes-market-2966 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312